ecopipam has been researched along with neostigmine in 1 studies
| Studies (ecopipam) | Trials (ecopipam) | Recent Studies (post-2010) (ecopipam) | Studies (neostigmine) | Trials (neostigmine) | Recent Studies (post-2010) (neostigmine) |
|---|---|---|---|---|---|
| 147 | 18 | 34 | 5,020 | 454 | 637 |
| Protein | Taxonomy | ecopipam (IC50) | neostigmine (IC50) |
|---|---|---|---|
| Acetylcholinesterase | Electrophorus electricus (electric eel) | 2.54 | |
| Cholinesterase | Homo sapiens (human) | 0.45 | |
| Acetylcholinesterase | Homo sapiens (human) | 1.1 | |
| Cholinesterase | Equus caballus (horse) | 2.93 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Acquas, E; Di Chiara, G | 1 |
1 other study(ies) available for ecopipam and neostigmine
| Article | Year |
|---|---|
Local application of SCH 39166 reversibly and dose-dependently decreases acetylcholine release in the rat striatum.
Topics: Acetylcholine; Animals; Benzazepines; Cholinesterase Inhibitors; Corpus Striatum; Dopamine Antagonists; Dose-Response Relationship, Drug; Male; Microdialysis; Neostigmine; Rats; Rats, Sprague-Dawley | 1999 |